Safety and Efficacy of Single Dose versus Multiple Doses of AmBisomeH for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial

Abstract

Background: Anti-leishmanial drug regimens that include a single dose AmBisomeH could be suitable for eastern African patients with symptomatic visceral leishmaniasis (VL) but the appropriate single dose is unknown. Methodology: A multi-centre, open-label, non-inferiority, randomized controlled trial with an adaptive design, was conducted to compare the… (More)

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Khalil2016SafetyAE, title={Safety and Efficacy of Single Dose versus Multiple Doses of AmBisomeH for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial}, author={Eltahir Awad Gasim Khalil and Teklu Weldegebreal and Brima Musa Younis and Raymond Omollo and Ahmed Mudawi Musa and Workagegnehu Hailu and Abuzaid Abdalla Abuzaid and Thomas P C Dorlo and Zewdu Hurissa and Sisay Yifru and William Haleke and Peter G Smith and Sally J Ellis and Manica Balasegaram and Ahmed Mohamed El-Hassan and Gerard J. Schoone and Monique K. Wasunna and Robert Kimutai and Tansy Edwards and Asrat Hailu}, year={2016} }